Imperial College London Featured PhD Programmes
Gdansk University of Technology Featured PhD Programmes
Queen’s University Belfast Featured PhD Programmes

amyloid PhD Projects, Programmes & Scholarships

We have 16 amyloid PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


We have 16 amyloid PhD Projects, Programmes & Scholarships

PhD saved successfully

Computer simulation of metal-amyloid interaction and its role in plaque formation

Alzheimer’s disease is one of the greatest healthcare challenges facing 21st century society. AD is associated with formation of fibrils and plaques in brain tissue that impair proper functioning of neurons. Read more

Investigating the link between amyloid-β oligomers, neuroinflammation and cognitive deficits in preclinical models for Alzheimer’s Disease

Currently four out of the five pharmacological treatments used for Alzheimer’s disease (AD) are acetylcholinesterase inhibitors aimed at boosting the amount of acetylcholine in the brain, with the fifth being an N-methyl-D-aspartate (NMDA) receptor antagonist. Read more

Next Generation High-Speed Atomic Force Microscopy in the Wolfson Imaging Facility

  Research Group: School of Physics and Astronomy
To better understand diseases and to develop new treatment options, we need to understand very fast biological processes occurring at single molecule level. Read more

Targeting protein acetylation to reduce microglia activation in neurodegenerative disorders

Recently, inhibitors of histone deacetylase enzymes (HDACs) have been identified as having potential therapeutic value for a range of neuronal disorders including Alzheimer’s disease, dementia and stroke [1, 2]. Read more

4-year PhD Studentship: Novel immunological mechanisms and treatment targets for depression: evidence from randomised designs

Low-grade systemic inflammation represents one promising avenue for new mechanistic explanation and therapeutic development for depression, but success of future trials of immunotherapies will depend of optimum target selection based on evidence of causality. Read more

Filtering Results